Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Characterization of insulin-like growth factor I binding sites in human bladder cancer cell lines

Summary

The role of insulin-like growth factor I (IGF-I) in the growth and development of bladder cancer cells was investigated using cultured human cell lines representing differentiated (RT-4, 5637) or undifferentiated (T-24, J-82, TCC-SUP) transitional cell carcinoma (TCC). In the presence of 2% serum, IGF-I significantly stimulated the growth of all cell lines. The proliferation of T-24, 5637, and RT-4 cells was more sensitive to IGF-I than that of J-82 and TCC-SUP cells. [125I]IGF-I binding to 5637 and J-82 cells was significantly higher than that to T-24 and TCC-SUP cells (P<0.001). RT-4 cells possessed the lowest binding capacity among the cell lines tested. Scatchard analysis of [125I]IGF-I binding to four of the five cell lines indicated a single binding site for IGF-I, with apparent dissociation constants (K d) of 1.27, 1.18, 1.34, and 1.39 nmol/l for TCC-SUP, J-82, 5637, and T-24, respectively. Therefore, the difference observed in [125I]IGF-I binding among the bladder cancer cell lines was attributed to the difference of IGF-I binding sites and not to a change in receptor binding affinity. Cross-linking studies supported the suggestion that [125I]IGF-I was bound to a receptor on these cells. The results indicate that cultured human bladder cancer cells contain functional IGF-I receptors. A differentiated cell line, RT-4, possesses significantly fewer IGF-I receptors than other cell lines. This suggests that the overexpression of IGF-I receptor may reflect the malignant potential of bladder cancer cells.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Berger MS, Greenfield C, Gullick WJ, Haley J, Downward J, Neal DE et al (1987) Evaluation of epidermal growth factor receptors in bladder tumors. Br J Cancer 56:533–537

  2. 2.

    Bleday R, Tzanakakis GN, Schwalke MA, Wanebo HJ, Vezeridis MP (1990) Epidermal growth factor stimulation and metastatic rate in human pancreatic carcinoma cell lines. J Surg Res 49:276–279

  3. 3.

    Eloch A (1984) Induced cell differentiation in cancer therapy. Cancer Treat Rep 68:199–205

  4. 4.

    Bunenik J, Baresova M, Viklicky V, Jakoubkova J, Sainerova H, Donner J (1973) Established cell line of urinary bladder carcinoma (T24) containing tumor-specific antigen. Int J Cancer 11:765–773

  5. 5.

    Czech MP (1989) Signal transmission by the insulin-like growth factors. Cell 59:235–238

  6. 6.

    Daughaday WH (1990) Editorial: the possible autocrine/paracrine and endocrine roles of insulin-like growth factors of human tumors. Endocrinology 127:1–4

  7. 7.

    D'Ercole AJ, Stiles AD, Underwood LE (1984) Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanism of action. Proc Natl Acad Sci USA 81:935–939

  8. 8.

    Dulak NC, Temin HM (1973) A partially purified polypeptide fraction from rat liver cell conditioned medium with multiplication-stimulating activity for embryo fibroblasts. J Cell Physiol 81:153–160

  9. 9.

    Fiorelli G, De Bellis A, Longo A, Giannini S, Natali A, Constantini A et al. (1991) Insulin-like growth factor-I receptors in human hyperplastic prostate tissue: characterization, tissue localization, and their modulation by chronic treatment with a gonadotropin-releasing hormone analog. J Clin Endocrinol Metab 72:740–746

  10. 10.

    Froesch ER, Schmid C, Schwander J, Zapf J (1985) Action of insulin-like growth factors. Annu Rev Physiol 47:443–467

  11. 11.

    Goustin AS, Leof EB, Shipley GD, Moses HL (1986) Growth factors and cancer. Cancer Res 46:1015–1029

  12. 12.

    Heldin C-H, Westermark B (1984) Growth factors: mechanism of action and relation to oncogeneses. Cell 37:9–20

  13. 13.

    Kurose H, Yamaoka K, Okada S, Nakajima S, Seino Y (1990) 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3]increases insulin-like growth factor I (IGF-I) receptors in clonal osteoblastic cells: study on interaction of IGF-I and 1,25-(OH)2D3. Endocrinology 126:2088–2094

  14. 14.

    Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 277:680–685

  15. 15.

    Laiho M, Keski-Oja J (1989) Growth factors in the regulation of pericellular proteolysis: a review. Cancer Res 49:2533–2553

  16. 16.

    Lee K, Smith P, Weiss GH, Cockett ATK (1990) Clonal growth of bladder cancer cells in a double layer soft agar assay: needless addition of multiple culture supplements. Urol Res 18:197–200

  17. 17.

    Liotta LA (1986) Tumor invasion and metastasis: role of the extracellular matrix. Rhoads memorial award lecture. Cancer Res 46:1–7

  18. 18.

    Lund PK, Moats-Staats BM, Hynes MA, Simmons JG, Jansen M, D'Ercole AJ, Van Wyk JJ (1986) Somatomedin C/insulin-like growth factor I and insulin-like growth factor II mRNAs in rat fetal and adult tissues. J Biol Chem 261:14539–14544

  19. 19.

    Messing EM, Reznikoff CA (1987) Normal and malignant human epithelium: in vitro effects of epidermal growth factor. Cancer Res 47:2230–2235

  20. 20.

    Monaghan P, Ormerod MG, O'Hare MJ (1990) Epidermal growth factor receptors and EGF-responsiveness of the human breast-carcinoma cell line PMC42. Int J Cancer 46:935–943

  21. 21.

    Murphy AJ, Bell GI, Friesen HG (1987) Tissue distribution of insulin-like growth factor I and II messenger ribonucleic acid in the adult rat. Endocrinology 12:1279–1282

  22. 22.

    Nayak SK, O'Toole C, Price ZH (1977) A cell line from an anaplastic transitional cell carcinoma of human urinary bladder. Br J Cancer 35:142–151

  23. 23.

    Neal DE, Marsh C, Bennet MK, Abel PD, Hall RR, Sainsbury JRC et al (1985) Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumors. Lancet I:366–368

  24. 24.

    Neal DE, Sharples L, Smith K, Fennelly J, Hall RR, Harris AL (1990) The epidermal growth factor receptor and the prognosis of bladder cancer. Cancer 65:1619–1625

  25. 25.

    O'Toole C, Price ZH, Ohnuki Y, Unsgaard B (1978) Ultrastructure, karyology and immunology of a cell line originated from a human transitional-cell carcinoma. Br J Cancer 38:64–76

  26. 26.

    Pilch PF, Czech MP (1980) The subunit structure of the high-affinity insulin receptor. J Biol Chem 255:1722–1731

  27. 27.

    Pollak MN, Polychronakos C, Yousefi S, Richard M (1988) Characterization of insulin-like growth factor I (IGF-I) receptors of human breast cancer cells. Biochem Biophys Res Commun 154:326–331

  28. 28.

    Reiss K, Ferber A, Travali S, Procu P, Phillips PD, Baserga R (1991) The protooncogene c-myb increases the expression of insulin-like growth factor I and insulin-like growth factor I receptor messenger RNAs by a transcriptional mechanism. Cancer Res 51:5997–6000

  29. 29.

    Rigby CC, Franks LM (1970) A human tissue culture cell line from a transitional cell tumor of the urinary bladder: growth, chromosome pattern and ultrastructure. Br J Cancer 24:746–754

  30. 30.

    Ritvos O, Rutanen E, Pekonen F, Jalkanen J, Suikkari A, Ranta T (1988) Characterization of functional type I insulin-like growth factor receptors from human choriocarcinoma cells. Endocrinology 122:395–401

  31. 31.

    Scatchard G 81949) The attractions of proteins for small molecules and ions. Ann NY Acad Sci 51:660–672

  32. 32.

    Sporn MB, Roberts AB (1985) Autocrine growth factors and cancer. Nature 313:745–747

  33. 33.

    Stracke ML, Engel JD, Wilson LW, Rochler MM, Liotta LA, Schiffmann E (1989) The type I insulin-like growth factor receptor is a motility receptor in human melanoma cells. J Biol chem 264:21544–21549

  34. 34.

    Talavera F, Reynolds RK, Roberts JA, Menon KM (1990) Insulin-like growth factor I receptors in normal and neoplastic human endometrium. Cancer Res 50:3019–3024

  35. 35.

    Weiss RE, Liu BC-S, Ahlering T, Dubean L, Droller MJ (1990) Mechanisms of human bladder tumor invasion: role of protease cathepsin. B. J Urol 144:798–804

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Iwamura, M., Ishibe, M., Sluss, P.M. et al. Characterization of insulin-like growth factor I binding sites in human bladder cancer cell lines. Urol. Res. 21, 27–32 (1993). https://doi.org/10.1007/BF00295188

Download citation

Key words

  • Human bladder cancer
  • IGF-I receptor